The stock of Telesis Bio Inc (TBIO) has gone up by 4.53% for the week, with a -4.44% drop in the past month and a -11.51% drop in the past quarter. The volatility ratio for the week is 35.21%, and the volatility levels for the past 30 days are 23.21% for TBIO. The simple moving average for the past 20 days is 12.52% for TBIO’s stock, with a -41.42% simple moving average for the past 200 days.
Is It Worth Investing in Telesis Bio Inc (NASDAQ: TBIO) Right Now?
The 36-month beta value for TBIO is also noteworthy at 1.76. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TBIO is 0.52M, and at present, short sellers hold a 5.71% of that float. The average trading volume of TBIO on September 30, 2024 was 1.47M shares.
TBIO) stock’s latest price update
Telesis Bio Inc (NASDAQ: TBIO)’s stock price has gone decline by -19.05 in comparison to its previous close of 3.99, however, the company has experienced a 4.53% increase in its stock price over the last five trading days. globenewswire.com reported 2024-09-25 that Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities
TBIO Trading at -6.89% from the 50-Day Moving Average
After a stumble in the market that brought TBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.76% of loss for the given period.
Volatility was left at 23.21%, however, over the last 30 days, the volatility rate increased by 35.21%, as shares sank -3.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.82% lower at present.
During the last 5 trading sessions, TBIO rose by +4.53%, which changed the moving average for the period of 200-days by -51.37% in comparison to the 20-day moving average, which settled at $2.86. In addition, Telesis Bio Inc saw -55.03% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TBIO
Current profitability levels for the company are sitting at:
- -2.01 for the present operating margin
- 0.33 for the gross margin
The net margin for Telesis Bio Inc stands at -2.83. The total capital return value is set at -0.79. Equity return is now at value -146.98, with -58.02 for asset returns.
Based on Telesis Bio Inc (TBIO), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at -3.08. The debt to equity ratio resting at 0.71. The interest coverage ratio of the stock is -11.92.
Currently, EBITDA for the company is -31.05 million with net debt to EBITDA at -0.93. When we switch over and look at the enterprise to sales, we see a ratio of 1.98. The receivables turnover for the company is 13.14for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.89.
Conclusion
In summary, Telesis Bio Inc (TBIO) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
